Valuation

RVMDREVOLUTION Medicines Inc

StockNasdaqالولايات المتحدةHealth careEU retail: available

+2.7% today · +307.4% over a year

1/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 17% of the instruments we score

Trend: among the best of its peers; Quality: among the weakest; priced higher than most peers. No dividend.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricRVMDSector medianvs median
P/E—28.8 · n=114—
P/B15.93.0 · n=197427% above
P/S421.33.8 · n=20311,124% above
EV/EBIT—24.1 · n=103—
Free-cash-flow yield−3.0%2.7% · n=188208% below
Dividend yield0.00%0.00% · n=216—
Return on equity−79.1%2.4% · n=1943,389% below
Return on invested capital−71.4%3.4% · n=1772,202% below
Gross margin—62.5% · n=152—
Net debt / EBITDA—1.19 · n=108—

Value factor: 10 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42.633.6—1.6%0.6%6/10
JNJJohnson & Johnson29.17.2—3.6%2.1%8/10
ABBVAbbVie79.9—33.53.6%3.0%5/10
MRKMerck114.68.7—4.4%2.3%8/10
UNHUnitedHealth25.13.418.66.7%2.3%9/10
TMOThermo Fisher Scientific35.74.735.22.9%0.3%8/10
AMGNAmgen26.319.724.04.4%2.3%6/10
GILDGILEAD—16.1—6.8%2.1%4/10
ABTAbbott28.53.426.84.1%3.0%5/10
PFEPfizer38.42.0—6.6%5.9%1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 يونيو 2026 · filed 05 أغسطس 2026